Sarah J Doran1, Rebecca J Henry1, Kari Ann Shirey2, James P Barrett1, Rodney M Ritzel1, Wendy Lai2, Jorge C Blanco3, Alan I Faden1, Stefanie N Vogel2, David J Loane1,4. 1. Department of Anesthesiology and Shock, Trauma and Anesthesiology Research (STAR) Center, University of Maryland School of Medicine, Baltimore, MD. 2. Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD. 3. Sigmovir Biosystems Inc., Rockville, MD. 4. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.
Abstract
OBJECTIVES: Respiratory infections in the postacute phase of traumatic brain injury impede optimal recovery and contribute substantially to overall morbidity and mortality. This study investigated bidirectional innate immune responses between the injured brain and lung, using a controlled cortical impact model followed by secondary Streptococcus pneumoniae infection in mice. DESIGN: Experimental study. SETTING: Research laboratory. SUBJECTS: Adult male C57BL/6J mice. INTERVENTIONS: C57BL/6J mice were subjected to sham surgery or moderate-level controlled cortical impact and infected intranasally with S. pneumoniae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury. MAIN RESULTS: At 3 days post-injury, S. pneumoniae-infected traumatic brain injury mice (TBI + Sp) had a 25% mortality rate, in contrast to no mortality in S. pneumoniae-infected sham (Sham + Sp) animals. TBI + Sp mice infected 60 days post-injury had a 60% mortality compared with 5% mortality in Sham + Sp mice. In both studies, TBI + Sp mice had poorer motor function recovery compared with TBI + PBS mice. There was increased expression of pro-inflammatory markers in cortex of TBI + Sp compared with TBI + PBS mice after both early and late infection, indicating enhanced post-traumatic neuroinflammation. In addition, monocytes from lungs of TBI + Sp mice were immunosuppressed acutely after traumatic brain injury and could not produce interleukin-1β, tumor necrosis factor-α, or reactive oxygen species. In contrast, after delayed infection monocytes from TBI + Sp mice had higher levels of interleukin-1β, tumor necrosis factor-α, and reactive oxygen species when compared with Sham + Sp mice. Increased bacterial burden and pathology was also found in lungs of TBI + Sp mice. CONCLUSIONS: Traumatic brain injury causes monocyte functional impairments that may affect the host's susceptibility to respiratory infections. Chronically injured mice had greater mortality following S. pneumoniae infection, which suggests that respiratory infections even late after traumatic brain injury may pose a more serious threat than is currently appreciated.
OBJECTIVES: <span class="Disease">Respiratory infections in the postacute phase of traumatic brain injury impede optimal recovery and contribute substantially to overall morbidity and mortality. This study investigated bidirectional innate immune responses between the injured brain and lung, using a controlled cortical impact model followed by secondary Streptococcus pneumoniae infection in mice. DESIGN: Experimental study. SETTING: Research laboratory. SUBJECTS: Adult male C57BL/6J mice. INTERVENTIONS: C57BL/6J mice were subjected to sham surgery or moderate-level controlled cortical impact and infected intranasally with S. pneumoniae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury. MAIN RESULTS: At 3 days post-injury, S. pneumoniae-infected traumatic brain injurymice (TBI + Sp) had a 25% mortality rate, in contrast to no mortality in S. pneumoniae-infected sham (Sham + Sp) animals. TBI + Sp miceinfected 60 days post-injury had a 60% mortality compared with 5% mortality in Sham + Sp mice. In both studies, TBI + Sp mice had poorer motor function recovery compared with TBI + PBSmice. There was increased expression of pro-inflammatory markers in cortex of TBI + Sp compared with TBI + PBSmice after both early and late infection, indicating enhanced post-traumatic neuroinflammation. In addition, monocytes from lungs of TBI + Sp mice were immunosuppressed acutely after traumatic brain injury and could not produce interleukin-1β, tumor necrosis factor-α, or reactive oxygen species. In contrast, after delayed infection monocytes from TBI + Sp mice had higher levels of interleukin-1β, tumor necrosis factor-α, and reactive oxygen species when compared with Sham + Sp mice. Increased bacterial burden and pathology was also found in lungs of TBI + Sp mice. CONCLUSIONS:Traumatic brain injury causes monocyte functional impairments that may affect the host's susceptibility to respiratory infections. Chronically injured mice had greater mortality following S. pneumoniae infection, which suggests that respiratory infections even late after traumatic brain injury may pose a more serious threat than is currently appreciated.
Authors: Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf Journal: Circ Res Date: 2014-10-31 Impact factor: 17.367
Authors: Rishabh Sharma; Sandy R Shultz; Marcus J Robinson; Antonio Belli; Margaret L Hibbs; Terence J O'Brien; Bridgette D Semple Journal: Brain Behav Immun Date: 2019-04-25 Impact factor: 7.217
Authors: David A Zygun; Danny J Zuege; Paul J E Boiteau; Kevin B Laupland; Elizabeth A Henderson; John B Kortbeek; Christopher J Doig Journal: Neurocrit Care Date: 2006 Impact factor: 3.210
Authors: David J Loane; Ana Pocivavsek; Charbel E-H Moussa; Rachel Thompson; Yasuji Matsuoka; Alan I Faden; G William Rebeck; Mark P Burns Journal: Nat Med Date: 2009-03-15 Impact factor: 53.440
Authors: Jan-Dirk Vermeij; Hamid Aslami; Kees Fluiter; Joris J Roelofs; Walter M van den Bergh; Nicole P Juffermans; Marcus J Schultz; Koen Van der Sluijs; Diederik van de Beek; David J van Westerloo Journal: J Neurotrauma Date: 2013-10-24 Impact factor: 5.269
Authors: Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier Journal: Science Date: 2016-04-21 Impact factor: 47.728
Authors: Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel Journal: J Exp Med Date: 2003-08-25 Impact factor: 14.307
Authors: Mathijs R Wirtz; Jiri Moekotte; Kirsten Balvers; Marjolein M Admiraal; Jean-Francois Pittet; Joe Colombo; Brant M Wagener; J Carel Goslings; Nicole Juffermans Journal: Intensive Care Med Exp Date: 2020-11-25
Authors: Adel Helmy; Eric Peter Thelin; Philipp Lassarén; Caroline Lindblad; Arvid Frostell; Keri L H Carpenter; Mathew R Guilfoyle; Peter J A Hutchinson Journal: J Neuroinflammation Date: 2021-09-25 Impact factor: 8.322